Necitumumab Intravenous and Phenylephrine and triprolidine
Determining the interaction of Necitumumab Intravenous and Phenylephrine and triprolidine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
Generic Name: phenylephrine / triprolidine
Brand name: Prohist LQ, Histex PE, Histex-PE
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Necitumumab Intravenous-Phenylephrine Complex
- Necitumumab Intravenous-Phenylephrine Eye Drops 10%
- Necitumumab Intravenous-Phenylephrine Eye Drops 2.5%
- Necitumumab Intravenous-Phenylephrine Hydrochloride
- Necitumumab Intravenous-Phenylephrine Hydrochloride Injection
- Necitumumab Intravenous-Phenylephrine Injection
- Phenylephrine and triprolidine-Necon
- Phenylephrine and triprolidine-Necon 0.5/35
- Phenylephrine and triprolidine-Necon 1/35
- Phenylephrine and triprolidine-Necon 1/50
- Phenylephrine and triprolidine-Necon 1/50 (28)
- Phenylephrine and triprolidine-Necon 7/7/7